Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;47(2):365-9.
doi: 10.1007/s11262-013-0932-0. Epub 2013 Jun 8.

Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein

Affiliations

Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein

Jean-Christophe Le Bayon et al. Virus Genes. 2013 Oct.

Abstract

Human parainfluenza viruses (hPIV) are pathogens responsible for upper and lower respiratory tract infections. We previously described clinical variant strains of hPIV-2 that display unusual large syncytial cytopathic effects. Their molecular characterization revealed a recurrent conserved specific amino acid substitution: A96T in the F2 subunit of the fusion glycoprotein F. The objective of this study was to investigate the contribution of this A96T substitution to the specific hyperfusogenic properties of the hPIV-2 variant strains. Based on a transient expression strategy, quantification of cell-cell fusion assays, and flow cytometry, we have shown that the A96T mutation strongly alters the fusogenic properties of F hPIV-2, highlighting this key residue in the F2 subunit and its possible role in fusion regulation. This work highlights the benefits of monitoring genetic and phenotypic changes of circulating strains to complete our understanding of Paramyxovirus fusion and related pathogenesis.

PubMed Disclaimer

Similar articles

References

    1. J Virol. 2007 Aug;81(15):8303-14 - PubMed
    1. FEBS J. 2009 Dec;276(24):7217-27 - PubMed
    1. J Clin Invest. 2005 Jul;115(7):1688-98 - PubMed
    1. J Gen Virol. 1998 Feb;79 ( Pt 2):279-89 - PubMed
    1. J Virol. 2009 Nov;83(21):10857-68 - PubMed

Publication types

Substances

LinkOut - more resources